CURRICULUM VITAE
Name: Hamid Reza
Surname: Raziee
Date of birth: 3 April 1972
Marital status: Married
Language: English (IELTS 7.5), French(DELF B1), Farsi
Office Address: Omid Oncology Hospital, Alandasht Sq, Kouhsangi st, Mashhad, Iran
Office Phone: +98 511 8430634
Fax: +98 511 8430249
Email: ,
MEDICAL EDUCATION:
1990- 1995: Medical School – Mashhad University of Medical Sciences (MUMS).
1995-1997: Imam Reza Hospital - MUMS - Internship (MD)
RADIATION ONCOLOGY TRAINING:
2001 – 2004: Radiation oncology residency training in MUMS
Three years of residency covering all oncology-related fields including adult and pediatric oncology, theoretical and practical training on radiation therapy, chemotherapy, hormone therapy, palliative care.
AWARDS / HONORS:
2004: Ranked second on National Iranian Boards Exam for Radiation Oncology
MEMBERSHIPS:
2006-Now: European Society of Medical Oncology (ESMO No: 6551)
2005- Now: Iranian Cancer Association
1998- Now: Iranian Medial Association (No: 66790)
EMPLOYMENT/ APPOINTMENTS:
2007 – Now: Vice Dean, Mashhad Cancer Research Center (MCRC), Mashhad University of Medical Sciences.
2007 – Now: Head of Scientific Committee, MCRC,Mashhad University of Medical Sciences.
2007 – Now: Member of University Staff Think Tank Group,Mashhad
2006 – Now: Director, International Office, Mashhad University of Medical Sciences.
2006 – Now: Member of MUMS Research Council
2006 – Now: Member of MUMS Nanotechnology Committee,Mashhad University of Medical Sciences.
2006 – Now: Member of Radiation Oncology Department Research Committee,Mashhad University of Medical Sciences.
2006 – Now: Member of Radiation Oncology Department Research Committee,Mashhad University of Medical Sciences.
2006 – Now: Member of Research Organizing Committee for Khorasan Province Universities
2006 – Now: Member of Sentinel Lymph Node Biopsy Educational Committee,Mashhad University of Medical Sciences.
2006: Member of Executive Committee, 6th National Iranian Seminar on Gastrointestinal Diseases
2006: Member of Executive Committee, 1th National Iranian Seminar on Gynecologic Diseases
2004 – Now: Assistant Professor, Department of Radiation Oncology, Mashhad University of Medical Sciences
2001 – 2003: Part Time Local Doctor, Les Medicins Sans Frontieres, Mashhad, Iran
1999 – 2001: Surgeon Aid, Mehr General Hospital, Mashhad, Iran
1997-1999: Head of Rivash Rural Health Clininc, Kashmar, Iran
COURSES AND SEMINARS ATTENDED:
2007: Research Methodology Workshop, Mashhad University of Medical Sciences, Mashhad, Iran
2007: Randomized Clinical Trial Workshop, Eli Lilly Pharmaceutical Company, Mashhad, Iran
2007: One-day Seminar and Workshop on Endosonography,Mashhad Razavi Hospital, Mashhad, Iran
2007: 31st Annual IAS Congress, Radiation Oncology Satellite, Iranian Association of Surgeons, Tehran, Iran
2007: Systematic Review International Workshop, Tehran University of Medical Sciences, Tehran, Iran
2006: Literature Search and Reference ManagingWorkshop, Mashhad University of Medical Sciences, Mashhad, Iran
2006: Research Management and Priority Setting Workshop,Mashhad University of Medical Sciences, Mashhad, Iran
2006: 3rd Congress of Iranian Cancer Association, Iranian Society of Pathology, Tehran, Iran
2006: 31th ESMO Congress, European Society of Medical Oncology, Istanbul, Turkey
2005: The First Esophageal and Cardia Cancer Summit, Digestive Diseases Research Center, The Center for International Research and Collaboration, Tehran, Iran
2005: Hybrid Course in Cancer Genetics,European School of Genetic Medicine, Web cast from ESGM’s Main Training Center at Bertinoro (ITALY), Tehran University of Medical Sciences, Tehran, Iran
2005: Cancer Epidemiology Workshop, Cancer Institute of Iran, School of Public Health – The University of Sydney, Iranian Molecular Medicine Network, Tehran, Iran
2005: 2nd Congress of Iranian Cancer Association, Iranian Society of Pathology, Tehran, Iran
2004: 1st From Bench to Bed Congress on Gastrointestinal Diseases,The Research Center for Gastroenterology & Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
PUBLICATIONS:
1.Raziee HR, Taghizadeh Kermani A, Ghaffarzadegan K, Shakeri MT, Ghavamnasiri MR, HER-2/neu Gene Overexpression in Resectable Gastric Cancer and its Relationship with Histopathologic Subtype, Grade, and Stage, In Press, Iranian Journal of Basic Medical Sciences
2.Abbaszadegan MR, Raziee HR, Afsharnezhad S, Ghafarzadegan K, Ghavamnasiri MR. Aberrant p16 Methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma. Int J Gastrointest Cancer. 2005;36(1):47-54.
3.Abbaszadegan MR. Afsharnezhad S, Raziee HR Ghafarzadegan K, Ghavamnasiri MR. P16/INK4a promoter hypermethylation in serum, blood and tumor of patients with esophageal squamous cell carcinoma. IJBMS (Iranian Journal of Basic Medical Sciences) , 2004; Vol.6, No.4, pp 4-8.
4.RazieeMB, Raziee HR, Norouzpour Sh. Primary undifferentiated small cell subglottic carcinoma, report of a rare case. The Iranian Journal of Otorhinolaryngology , January 2002; Vol3&4, pp 8-12.
5.Seilanian Toosi M, Homaei F, Raziee HR. A Review in 17 Cases of Malignancy-Associated Neurofibromatosis Type I During 10 years, Iranian Journal of Dermatology, 2004; 28:242-246
6.Foroughipour M, Raziee HR et al. Response of Myastenia Gravis to the Treatment of Precursor T-Cell Lymphoma, Report of a Rare Case. Urmia Medical Journal 2004;1(15): 55-60
POSTERS:
1.Non-hodgkin's lymphoma, report of 888 cases during 23 years (1977-2000) with special attention to gastrointestinal lymphoma, Salehi MH, Raziee HR, Poster, 8th annual congress of the European Hematology Association, Lyon, France, 12-15 June 2003
2.Hodgkin's Disease, Report of 183 cases during 18 years (1983-2000), Salehi MH, Raziee HR, Poster, 8th annual congress of the European Hematology Association, Lyon, France, 12-15 June 2003
3.Aberrant p16 methylation, a possible predisposieng factor in familial esophageal squamous cell carcinoma, Abbaszadegan MR, Raziee HR, Afsharnezhad S, Ghafarzadegan K, Ghavamnasiry MR, Poster, 95th annual meeting of the American Association For Cancer Research (AACR), Orlando, Florida, USA, March 27-31, 2004
LECTURES:
2007: Molecular Prognostic Markers in Gastric Cancer,31st Annual IAS Congress, Radiation Oncology Satellite, Iranian Association of Surgeons, Tehran, Iran
2006: Epidemiology of Lymphoma in Khorasan, Iran (CME), Mashhad University of Medical Sciences
2006: Lymphoma Pathology Reviews and Sample Banking, Experience of Mashhad University, 3rd Congress of Iranian Cancer Association, Iranian Society of Pathology, Tehran, Iran
2005: Genetic Effects of Radiation (CME), Mashhad University of Medical Sciences
2005: Radiation Dosimetry (CME), Mashhad University of Medical Sciences
2005: Novel Molecular Markers in Esophageal Cancer,Cancer Molecular Epidemiology Workshop,Cancer Institute of Iran, School of Public Health – The University of Sydney, Iranian Molecular Medicine Network, Tehran, Iran
2005: Radioimmunotherapy for Lymphomas, 2nd Congress of Iranian Cancer Association, Iranian Society of Pathology, Tehran, Iran
2004: P16 as a novel molecular marker in esophageal cancer patients,Bu-Ali Research Institute, Mashhad, Iran.
2004: Diagnosis of Malignancy by Serum Nucleic Acids Assessment, Bu-Ali Research Institute, Mashhad, Iran.
THESIS LEADING / CONSULTATIONS:
2007: The Effect of Physical Exercise on the Quality of Life in Breast Cancer Patients – A Randomized Clinical Trial, MsC Thesis of Physical Education and Sport Sciences, Mashhad Ferdowsi University
2006: Calculation of Posterior Rectal Wall Dose in Pelvic External Radiation Fields by Rando Phantom Radiation. Medical Physics MsC Thesis, Mashhad University of Medical Sciences
2006: Relationship between Opium Addiction and Laryngeal Cancer Development. General Medicine Thesis, Mashhad University of Medical Sciences
2004: HER-2/neu Gene Overexpression in Resectable Gastric Cancer and its Relationship with Histopathologic Subtype, Grade, and Stage, Radiation Oncology Specialty Thesis, Mashhad University of Medical Sciences
RESEARCH PROJECTS LEADING / COLLABORATION:
2007: Microsatellite Instability in Serum and Tumor Tissues in Gastric Cancer and Its Relationship with hMLH1 Methylation, Research Grant from Mashhad University of Medical Sciences.
2007: Assessment of MALT Grade And Gastritis in Gastric Endoscopic Biopsies and Its Relationship with h Pylori Infection, Research Grant from Mashhad University of Medical Sciences.
2007: Assessment of MALT Grade And Gastritis in Gastric Endoscopic Biopsies and Its Relationship with h Pylori Infection, Research Grant from Mashhad University of Medical Sciences.
2007: MGMT Protein Expression and Its Gene Methylation in Glioblastoma Multiforme Patients, Research Grant Requested from Mashhad University of Medical Sciences.
2007: A 5-year Retrospective Review on Pathology Classification and Clinical Characteristics in Hodgkin’s Lymphomas in MUMS University Hospitals, Research Grant from Mashhad University of Medical Sciences.
2007: A Phase II Study of Preoperative Chemoradiotherapy in Esophageal Cancer, Research Grant from Mashhad University of Medical Sciences.
2007: HCV Assessment in Aggressive Lymphomas, Research Grant Requested from Mashhad University of Medical Sciences.
2006: The Effect of Preoperative Chemoraditherapy in Esophageal SCC on p16 Methylation Profile Change. Research Grant Requested from Mashhad University of Medical Sciences.
2006: Methylation Assay in 5 Genes (hMLH1, RASSF1A, E-Cadherin, MGMT, DAP Kinase) In Gastric Cancer, Research Grant from Mashhad University of Medical Sciences.
2006: Serum Fas and FasL in Aggressive Lymphomas and Its Relation with Response to Chemotherapy, Research Grant from Immunology Research Center, Mashhad University of Medical Sciences.
2006: Assessment of GST Gene Polymorphisms in Esophageal Cancer and Its Relationship with p16 Gene Methylation and PAH Exposure, Research Grant from Mashhad University of Medical Sciences.
2005: Prediction of Treatment Response In Aggressive Lymphomas by Tc-Sestamibi Scan. Research Grant from Mashhad University of Medical Sciences.
2005: Prediction of Treatment Response In Aggressive Lymphomas by Changes in Serum IL-6, IL2 and IL-10 Levels. Research Grant from Mashhad University of Medical Sciences.
2005: Prediction of Response to Preoperative Chemotherapy in Osteosarcoma by Two-Stage Tc-Sestamibi Scan, Research Grant from Mashhad University of Medical Sciences.
ACTIVITIES IN ONCOLOGY FIELD:
2007Founding Mashhad University Cancer Research Center (MCRC) (One of 5 founders)
2004Founding Mashhad University Lymphoma Registry Unit(One of six founders)
Setting up “MUMS Lymphoma Research Committee” consisting of a Registry Unit, BiobankingFacility and a Lymphoma Workgroup comprised of different lymphoma-related specialists.
2004 – Now: Treatment Experiences:
Yearly around 1800 patient follow up visits from which 200 are new cases
Delivery of different modes of external radiotherapy techniques by Cobalt-60 and Linear Accelerator (9MV) units
Delivery of different chemotherapy and hormone therapy regimens for a vast variety of cancer patiens
2004 – Now: Educational Experiences:
Yearly 2 new Radiation Oncology specialty residents
Weekly Journal Clubs
Clinical Ward Rounds
Weekly Reference Review Sessions
Active Involvement in Practical Training to Residents at Clinics and on Radiation Treatment Settings
REFERENCES:
Jalil Tavakkol Afshari, MSc., PhD., MT(ASCP), CLS(NCA), Associate Professor, Vice Chancellor for Research, Head, Immunogenetics and Tissue Culture Dept.,Bu-Ali Research Institute, Mashhad University of Medical Sciences(MUMS), Mashhad – Iran, Tel:+98 511 8411538, Fax:+98 511 8430249, Emails: , , web:
Mohammad Reza GhavamNassiriMD, Associate Professor, Radiation Oncologist, Head, Radiation Oncology Dept., Mashhad University of Medical Sciences(MUMS), Mashhad – Iran, Tel:+98 511 8426084, Fax:+98 511 8430249, Email:
Reza MalekzadehMD, Professor of Medicine, Director Digestive Disease Research Center, Shariati Hospital,Kargar Shomali Avenue, Tehran University of Medical Sciences, Tehran, Iran, Email:, Telephon:009821-88026481, Fax:009821-22253536
6/18/07 - Page 1 of 6